Compartir
Información de la revista
Lo más leído
34493
Myths and conspiracy theories on vaccines and COVID-19: Potential effect on global vaccine refusalsI. Ullah, K.S. Khan, M.J. Tahir, A. Ahmed, H. Harapan
Vacunas. 2021;22:93-7
34493
3849
The SARS-CoV-2, a new pandemic zoonosis that threatens the worldJ. Reina
Vacunas. 2020;21:17-22
3849
Acceso a texto completo
Artículo abierto
2635
Vaccination with conjugate vaccines against pneumococcal disease: What really mattersJ.C.De Moraes, X.M. Pérez Porcuna, J. Nieto-Guevara, A. Eisman, B. Torres, J.L. Gonzalez Redondo, X. Saez-Llorens
Vacunas. 2020;21:23-40
2635
Open access
2582
Obesity, immunity and vaccinationF. Fariñas Guerrero, R.M. López Gigosos
Vacunas. 2021;22:174-82
2582
Open access
1591
Recent advances in the prevention of meningococcal B disease: Real evidence from 4CMenB vaccinationF. Martinón-Torres, A. Banzhoff, C. Azzari, P. de Wals, R. Marlow, H. Marshall, M. Pizza, R. Rappuoli, R. Bekkat-Berkani
Vacunas. 2021;22:189-202
1591
Open access
1033
Transmission of SARS CoV-2 virus through the ocular mucosa worth taking precautionsA.A. Dawood
Vacunas. 2021;22:56-7
1033
994
COVID-19 and primary care: A perspective from ItalyF. Ghidinelli, F. Martire
Vacunas. 2021;22:209-11
994
833
Analysis of the best strategies to promote flu vaccination coverage among healthcare professionalsEsther Redondo, Néboa Zozaya, Vicente Martín, Javier Villaseca, Juan Luis López-Belmonte, Georgina Drago, Elena Jurío, Álvaro Hidalgo-Vega
Vacunas. 2022;23:97-105
833
Open access
768
Incidence of herpes zoster and its complications in ≥50-year-old Spanish adults: A prospective cohort studyLuis García Comas, Teresa Cerdán, Maria Del Rosario Cambronero, Juan Antonio García Martínez, Marta López Sanromà, Kusuma Gopala, Benedetto Simone, Javier Díez-Domingo
Vacunas. 2022;23:165-73
768
Open access
566
SEPAR recommendations and new challenges on COVID-19 vaccine in respiratory diseasesD. de la Rosa-Carrillo, J.L. López-Campos, M. Blanco Aparicio, F. Villar-Álvarez
Vacunas. 2021;22:131-4
566
504
Diagnosis of COVID-19 in symptomatic patients: An updated reviewM.N. Zahan, H. Habibi, A. Pencil, J. Abdul-Ghafar, S.A. Ahmadi, N.S. Juyena, M.T. Rahman, M.S. Parvej
Vacunas. 2022;23:55-61
504
431
Menstrual abnormalities after COVID-19 vaccines: A systematic reviewMaheen Nazir, Shumaila Asghar, Muhammad Ali Rathore, Asima Shahzad, Anum Shahid, Alishba Ashraf Khan, Asmara Malik, Tehniat Fakhar, ... Jahanzeb Malik
Vacunas. 2022;23 Supl 2:S77-S87
431
402
Collateral effects of Covid-19 pandemic emergency response on worldwide immunizationsN. Torner
Vacunas. 2020;21:73-5
402
358
Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021N. Alvis-Guzman, J. Alvis-Zakzuk, J. Paz-Wilches, J.C. Fernandez-Mercado, F. de la Hoz-Restrepo
Vacunas. 2021;22:138-49
358
356
Immuno-informatics design of a multimeric epitope peptide-based vaccine against dengue virus serotype-2Mohamed Sheik Tharik Abdul Azeeze, Rajaguru Arivuselvam
Vacunas. 2023;24:380-93
356
297
Autoimmune diseases related to post-SARS-CoV-2 vaccination: A rheumatology perspectiveFarhad Dadgar, Jorge Casseb, Masoud Keikha
Vacunas. 2023;24:400-1
297
284
The status of COVID-19 vaccines in India: A reviewDeepak Kumar Jha, Kumar Pranay, Samiksha, Amit Kumar, Niti Yashvardhini
Vacunas. 2023;24:218-47
284
165
Autumn 2023 SARS-CoV-2 immunization: Who should be vaccinated and how?Fernando Moraga-Llop, Magda Campins-Martí
Vacunas. 2023;24:261-5
165
155
The end of COVID-19 public health emergency of international concern (PHEIC): And now what?Núria Torner
Vacunas. 2023;24:164-5
155